DukeHealth

DURHAM, N.C. November 14, 2016 – When patients suffer from atrial fibrillation, an irregular heartbeat, they are at considerably higher risk for blood clots and stroke. However, when hospitalized, half of these patients do not receive medications that could help prevent such complications, according to research being presented Nov. 14 at the American Heart Association […]

Ticagrelor proved no better than clopidogrel for patients with peripheral artery disease DURHAM, N.C. November 13, 2016 – The finding that the drug ticagrelor proved no better than clopidogrel in reducing cardiovascular events for patients with peripheral artery disease should both assure patients about current treatments and demonstrate that new options are still needed, Duke Clinical […]